Position in RDY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$13,850
-$190 QoQ
Shares Held
1,000
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BROWN BROTHERS HARRIMAN & CO holds $168,196,691 across 13 Drug Manufacturers - Specialty & Generic names. RDY ranks #6 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,416,566 | $167,452,266 | |
| 2 | VTRS |
Viatris Inc
|
29,552 | $399,247 | |
| 3 | HLN |
Haleon plc
|
15,232 | $152,472 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
6,812 | $126,158 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
40 | $23,719 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
This page
|
1,000 | $13,850 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
187 | $9,666 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
243 | $8,036 |
All Filings in RDY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,850 | 1,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $14,040 | 1,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,990 | 500 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $14,443 | 961 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||